Cargando…
Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets
Meningiomas are the most common primary CNS tumors. They are usually benign but can present aggressive behavior in about 20% of cases. The genetic landscape of meningioma is characterized by the presence (in about 60% of cases) or absence of NF2 mutation. Low-grade meningiomas can also present other...
Autores principales: | Maggio, Ilaria, Franceschi, Enrico, Di Nunno, Vincenzo, Gatto, Lidia, Tosoni, Alicia, Angelini, Daniele, Bartolini, Stefania, Lodi, Raffaele, Brandes, Alba Ariela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534341/ https://www.ncbi.nlm.nih.gov/pubmed/34679551 http://dx.doi.org/10.3390/diagnostics11101852 |
Ejemplares similares
-
Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas
por: Maggio, Ilaria, et al.
Publicado: (2021) -
Glioblastoma: Emerging Treatments and Novel Trial Designs
por: Di Nunno, Vincenzo, et al.
Publicado: (2021) -
Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review
por: Gatto, Lidia, et al.
Publicado: (2021) -
Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology
por: Gatto, Lidia, et al.
Publicado: (2022) -
Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?
por: Gatto, Lidia, et al.
Publicado: (2022)